A full audience for this session reflected the growing interest in CIDP, autoimmune nodopathies and complement-targeted therapies.

Can someone have Alzheimer's disease before they develop symptoms? This fascinating workshop explored why the answer depends on how we define the disease—and why that debate matters more than ever in the era of disease-modifying therapies.

From headache and sleep to epilepsy and public health, the Public Brain Health Day brought one message clearly into focus: protecting brain health starts well beyond the clinic

From award-winning discoveries to AI, biomarkers and precision medicine, this popular session captured the biggest ideas of the EAN Congress 2026 and looked ahead to Gothenburg 2027 under new EAN leadership.

A powerful EAN TV session showing how narcolepsy, ME/CFS and restless legs syndrome shape daily life and how smarter digital tools could finally help patients manage sleep, pain and fatigue more effectively.

A fascinating EAN TV session showed how neurology has evolved from Broca’s early localisation experiments to today’s personalised digital brain twins, revealing just how far our understanding of brain networks has come.

EAN Website editor Letizia Leocani and Communications Committee member Agne Straukiene talk to Prof. John Rothwell, who delivered the Charles-Édouard Brown-Sequard Lecture at the EAN Congress 2026

Interview with Frank Winkler, who delivered the Brain Prize Lecture during the Opening Session of the 12th Congress of the European Academy of Neurology.

Migraine is a major focus of current neurological practice, with several new guideline recommendations highlighting migraine‑specific treatments. This growing interest was reflected in a packed room at EAN 2026.

This session brought together global, European, and national perspectives to discuss an urgent question: how can we move from recognising the burden of neurological disorders to acting on it more effectively?

This session changed the way participants will approach a febrile neurological presentation. The mosquito is now a neurologist's problem, and the time to update our thinking is now.

The second day of the EAN Congress 2026 closed with a session that was both scientifically rich and clinically important, hosted in collaboration with the European Society of Cardiology.

The EAN Congress 2026 Presidential Symposium in Geneva offered a compelling snapshot of modern neurology in motion – a field increasingly defined by its ability to turn scientific discovery into tangible benefits for patients.

This session introduced The Michael J. Fox Foundation (MJFF), a US-based non-profit that has funded Parkinson's disease (PD) research since 2000.

This EAN TV session, in cooperation with EFNA, set the spotlight on the patient’s perspective in rare neurological diseases.